Brief: ProQR Therapeutics NV Files For Resale Of Up To 3.7 Million Ordinary Shares By The Selling Shareholders
01/03/2022 22:36
March 1 (Reuters) -
* PROQR THERAPEUTICS NV FILES FOR RESALE OF UP TO 3.7
MILLION
ORDINARY SHARES BY THE SELLING SHAREHOLDERS - SEC FILING
Further company coverage: PRQR.O
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview